The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 350:947-948 February 26, 2004 Number 9
NextNext

Gene Silencing

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Herman, J. G.
-PubMed Citation
To the Editor: Herman and Baylin (Nov. 20 issue)1 provide an excellent review of gene silencing in cancer in association with promoter hypermethylation. However, some readers who are new to the field will be confused by the introductory section of their article — in particular, the authors' explanation of the term "epigenetic," which suggests that this term describes "a heritable change in the pattern of gene expression." In fact, in this context, promoter hypermethylation is a somatic event, and although it may be passed on to daughter somatic cells, it is not heritable in the germ line. Although it is . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.